RB1 and neoplasm: Three studies focused on in vitro differentiation of RB1 mutant human pluripotent stem cells into retinal organoids for 90 to 150 days, whereas one study investigated tumor formation of organoid-derived cells of d45 in orthotopic xenograft models.